InvestSMART

Pro Medicus Limited (ASX: PME) - Announcements

Current share price for PME : $181.480 2.24 (1.25%)+

ASX company news and announcements for Pro Medicus Limited (PME) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pro Medicus Limited (PME) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pro Medicus Limited (PME), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pro Medicus Limited (PME)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18,959 Update - Notification of buy-back - PME 20 Jun 2022 9:33AM $37.860 $181.480 risen by 379.34%
$18,959 Update - Notification of buy-back - PME 16 Jun 2022 9:05AM $39.420 $181.480 risen by 360.38%
$18,959 Update - Notification of buy-back - PME 15 Jun 2022 8:47AM $39.110 $181.480 risen by 364.02%
$18,959 Update - Notification of buy-back - PME 14 Jun 2022 10:53AM $39.110 $181.480 risen by 364.02%
$18,959 PME signs two contract renewals - A$47M 14 Jun 2022 9:32AM $39.110 $181.480 risen by 364.02%
$18,959 Update - Notification of buy-back - PME 10 Jun 2022 8:43AM $41.310 $181.480 risen by 339.31%
$18,959 Update - Notification of buy-back - PME 8 Jun 2022 8:46AM $41.590 $181.480 risen by 336.35%
$18,959 Form 484 - Cancellation of Shares 3 Jun 2022 9:38AM $41.140 $181.480 risen by 341.13%
$18,959 PME signs A$28M, 7 year deal with Allina Health 2 Jun 2022 9:10AM $41.290 $181.480 risen by 339.53%
$18,959 Update - Notification of buy-back - PME 30 May 2022 10:20AM $42.020 $181.480 risen by 331.89%
$18,959 Update - Notification of buy-back - PME 26 May 2022 8:34AM $39.600 $181.480 risen by 358.28%
$18,959 Update - Notification of buy-back - PME 19 May 2022 8:55AM $40.230 $181.480 risen by 351.11%
$18,959 Update - Notification of buy-back - PME 18 May 2022 9:16AM $40.110 $181.480 risen by 352.46%
$18,959 Update - Notification of buy-back - PME 16 May 2022 9:13AM $41.020 $181.480 risen by 342.42%
$18,959 Update - Notification of buy-back - PME 13 May 2022 8:59AM $40.650 $181.480 risen by 346.45%
$18,959 Update - Notification of buy-back - PME 12 May 2022 9:35AM $42.270 $181.480 risen by 329.34%
$18,959 Update - Notification of buy-back - PME 10 May 2022 9:25AM $40.760 $181.480 risen by 345.24%
$18,959 PME signs A$32M, 8 year deal with Inova Health 8 Apr 2022 9:44AM $47.200 $181.480 risen by 284.49%
$18,959 Notification of buy-back - PME 1 Apr 2022 9:13AM $48.990 $181.480 risen by 270.44%
$18,959 On Market share buy-back Appendix 3F 1 Apr 2022 9:08AM $48.990 $181.480 risen by 270.44%
$18,959 Form 484 - Cancellation of Shares 1 Apr 2022 9:03AM $48.990 $181.480 risen by 270.44%
$18,959 Daily share buy-back notice - Appendix 3E 15 Mar 2022 8:54AM $43.980 $181.480 risen by 312.64%
$18,959 Daily share buy-back notice - Appendix 3E 8 Mar 2022 8:56AM $43.780 $181.480 risen by 314.53%
$18,959 Form 484 - Cancellation of Shares 7 Mar 2022 9:36AM $46.170 $181.480 risen by 293.07%
$18,959 Daily share buy-back notice - Appendix 3E 25 Feb 2022 9:49AM $45.420 $181.480 risen by 299.56%

276 - 300 of 679 results

Page 12 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.